Summary Developed by an expert working group of representatives from the Australian Diabetes Society (ADS), Australian Diabetes Educators Association (ADEA), Royal Australian College of General Practitioners (RACGP) and Dietitians Australia,

Summary A joint guideline by the Australian Diabetes Society (ADS) and Australian and New Zealand Society of Nuclear Medicine (ANZSNM) for PET/CT imaging in patients with type 1 and type

Summary The blood glucose management algorithm for type 2 diabetes outlines the risks, benefits and costs of available therapies and provides an approach for how to incorporate older and newer

Summary Guidance concerning the use of glycated haemoglobin (HbA1c) for the diagnosis of diabetes mellitus Position Statement The use of glycated haemoglobin (HbA1c) for diagnosis of diabetes mellitus has been

Summary  The ADS together with ADEA and ANZCA have made an update to the Alert – ‘Periprocedural Diabetic Ketoacidosis (DKA) with SGLT2 Inhibitor use in People with Diabetes’ incorporating recently published

ADS Position Statement ‘Medical Certification of Persons with Insulin-treated Diabetes in the Aviation Industry’   This is the first ADS supported position statement to address medical certification of diabetes in

The prevalence of diabetes is rising and so too is the complexity of diabetes management. There is an increasing number of diabetes medication classes and of medications within each of

Optimal initial medication We suggest the use of metformin as first-line monotherapy in adults with type 2 diabetes. Optimal Add-On Medication We recommend the addition of an SGLT-2 inhibitor to

SummaryThe Australian Diabetes Society together with the Australian Diabetes Educators Association and Australasian Paediatric Endocrine Group have written the first ever Australian consensus statement on the management of type 2 diabetes in young adults. The consensus statement provides